Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries - The current and future state of the art

Despite three decades of accumulating evidence, harm reduction interventions for HIV prevention among PWID remain under-utilized, particularly in LMIC. “Getting to Zero” new infections among PWID will require not only better and more compelling evidence to end, finally and completely, the scientific debate on harm reduction but also the more effective deployment of that evidence to advocate for and achieve universal adoption of harm reduction interventions.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.